NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: VIGILAIR Systems, Inc.

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Memorial Sloan-Kettering Cancer Center Implements New Lab Disinfection System - Genetic researchers have a greener way to keep their labs free from organic contamination. A new technology utilizing Ultraviolet light replaces manual cleaning. The technology is safe, effective and environmentally friendly - VIGILAIRSystems.com
Memorial Sloan-Kettering Cancer Center Implements New Lab Disinfection System

 

NewswireTODAY - /newswire/ - North Tonawanda, NY, United States, 2009/02/03 - Genetic researchers have a greener way to keep their labs free from organic contamination. A new technology utilizing Ultraviolet light replaces manual cleaning. The technology is safe, effective and environmentally friendly - VIGILAIRSystems.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The gene therapy research community is turning to a novel technology to keep their lab free from contamination. Gene therapy research labs require extremely high standards for cleanliness. Traditionally researchers at Memorial Sloan Kettering Cancer Center (MSKCC) relied on manual surface cleaning using caustic chemicals to meet those standards.

Managers at the Gene Transfer and Somatic Cell Engineering Facility were looking for an alternative because the existing cleaning procedure is labor intensive, costly and yields mixed results.

A VIGILAIR® Room Surface Sterilization System (RSS) was installed in the lab to determine its efficacy in reducing microorganisms that could contaminate the work area. Separate tests by MSKCC and VIGILAIR® showed the RSS system provided a 5 log or greater reduction on target pathogens.

RSS uses Ultraviolet energy (UV-C) to deactivate microorganisms that contaminate surfaces. UV-C emitters are strategically placed to bathe the entire lab with germicidal UV-C energy. RSS features sophisticated controls that turn off the emitters when a predetermined UV dose is achieved. The system also prevents lab workers from being accidentally exposed to UV.

“The testing results are very encouraging, “ says VIGILAIR Systems, Inc. President Peter Bjorkman. “The results clearly demonstrate that our UV technology is a safe and cost effective alternative to manual cleaning.”

About VIGILAIR Systems, Inc.

VIGILAIR Systems (vigilairsystems.com) is the industry leader in the use of evidence based design for UV surface and air disinfection. Based in New York State, VIGILAIR® serves clients worldwide. VIGILAIR® major market segments are Healthcare, Nutraceutical Manufacturing and Bio-Defense.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: VIGILAIR Systems, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Memorial Sloan-Kettering Cancer Center Implements New Lab Disinfection System

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Joel Dombrowski - VIGILAIRSystems.com 
716-692-8843 Joel.Dombrowski[.]VIGILAIRsystems.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any VIGILAIR Systems, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From VIGILAIR Systems, Inc. / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Frost & Sullivan Awards Avance Clinical for Global Biotech CRO Excellence, Highlighting Agility, Responsiveness, Customer Value
BASF Declares Force Majeure for Selected Vitamin A, Vitamin E, and Carotenoid Products As Well As Selected Aroma Ingredients
Ono Pharmaceutical Co., Ltd Enters into A New Option and Research Collaboration Agreement with Monash University
Aragen Life Sciences Ltd Receives the 2024 Global Customer Value Leadership Award from Frost & Sullivan for Pioneering Excellence in Drug Discovery
Ipsen’s Iqirvo® Receives U.S. FDA Accelerated Approval as A First-in-class PPAR Treatment for Primary Biliary Cholangitis
Ipsen Presents Long-term Elafibranor Efficacy and Itch-related Quality of Life Data in Patients with Primary Biliary Cholangitis
HUB Organoids B.V. Awarded Frost & Sullivan’s 2024 Technology Innovation Leadership Award for Transforming Drug Development
Immunology Consultants Laboratory Rebrand Highlights R&D and Service Specializations
Ipsen and Skyhawk Therapeutics Announce RNA Targeting Research Collaboration in Rare Neurological Diseases
Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer At AACR 2024
Bruker Showcases High-Performance Solutions at Analytica 2024 for Research and Analysis in Applied, Industrial and Biopharma Laboratories
STEMCELL Technologies Announces FDA De Novo Classification for Its EasySep™ CD138 Positive Selection Kit to Support Cancer Diagnostic Tests
ONO Implements Oracle's CTMS for Global Centralized Management of Clinical Trials
BASF Aroma Ingredients Expands its Isobionics® Portfolio with New Natural Flavors
Bruker Completes Acquisition of Optical Cell Imaging Company Phasefocus

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  RightITnow, Inc.





 
  ©2005-2024 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)